FDA Inspection 1168612 — ECI Pharmaceuticals, LLC
The FDA completed an inspection of ECI Pharmaceuticals, LLC on Apr 22, 2022 in Ft Lauderdale, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 22, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ft Lauderdale, FL (United States)